IBDEI05R ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7423,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7423,1,4,0)
 ;;=4^OSTEOPOROSIS,IDIOPATHIC
 ;;^UTILITY(U,$J,358.3,7423,1,5,0)
 ;;=5^733.02
 ;;^UTILITY(U,$J,358.3,7423,2)
 ;;=^272692
 ;;^UTILITY(U,$J,358.3,7424,0)
 ;;=733.03^^65^558^9
 ;;^UTILITY(U,$J,358.3,7424,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7424,1,4,0)
 ;;=4^OSTEOPOROSIS,DISUSE
 ;;^UTILITY(U,$J,358.3,7424,1,5,0)
 ;;=5^733.03
 ;;^UTILITY(U,$J,358.3,7424,2)
 ;;=^265526
 ;;^UTILITY(U,$J,358.3,7425,0)
 ;;=733.09^^65^558^10
 ;;^UTILITY(U,$J,358.3,7425,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7425,1,4,0)
 ;;=4^OSTEOPOROSIS,DRUG-INDUCED
 ;;^UTILITY(U,$J,358.3,7425,1,5,0)
 ;;=5^733.09
 ;;^UTILITY(U,$J,358.3,7425,2)
 ;;=^87762
 ;;^UTILITY(U,$J,358.3,7426,0)
 ;;=268.2^^65^558^6
 ;;^UTILITY(U,$J,358.3,7426,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7426,1,4,0)
 ;;=4^OSTEOMALACIA NOS
 ;;^UTILITY(U,$J,358.3,7426,1,5,0)
 ;;=5^268.2
 ;;^UTILITY(U,$J,358.3,7426,2)
 ;;=^87103
 ;;^UTILITY(U,$J,358.3,7427,0)
 ;;=756.52^^65^558^7
 ;;^UTILITY(U,$J,358.3,7427,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7427,1,4,0)
 ;;=4^OSTEOPETROSIS
 ;;^UTILITY(U,$J,358.3,7427,1,5,0)
 ;;=5^756.52
 ;;^UTILITY(U,$J,358.3,7427,2)
 ;;=^87143
 ;;^UTILITY(U,$J,358.3,7428,0)
 ;;=579.9^^65^558^1
 ;;^UTILITY(U,$J,358.3,7428,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7428,1,4,0)
 ;;=4^MALABSORPTION SYNDROME
 ;;^UTILITY(U,$J,358.3,7428,1,5,0)
 ;;=5^579.9
 ;;^UTILITY(U,$J,358.3,7428,2)
 ;;=^123941
 ;;^UTILITY(U,$J,358.3,7429,0)
 ;;=275.40^^65^558^2
 ;;^UTILITY(U,$J,358.3,7429,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7429,1,4,0)
 ;;=4^METABOLISM D/O,CALCIUM
 ;;^UTILITY(U,$J,358.3,7429,1,5,0)
 ;;=5^275.40
 ;;^UTILITY(U,$J,358.3,7429,2)
 ;;=^18161
 ;;^UTILITY(U,$J,358.3,7430,0)
 ;;=275.2^^65^558^3
 ;;^UTILITY(U,$J,358.3,7430,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7430,1,4,0)
 ;;=4^METABOLISM D/O,MAGNESIUM
 ;;^UTILITY(U,$J,358.3,7430,1,5,0)
 ;;=5^275.2
 ;;^UTILITY(U,$J,358.3,7430,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,7431,0)
 ;;=275.3^^65^558^5
 ;;^UTILITY(U,$J,358.3,7431,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7431,1,4,0)
 ;;=4^METABOLISM D/O,PHOSPHORUS
 ;;^UTILITY(U,$J,358.3,7431,1,5,0)
 ;;=5^275.3
 ;;^UTILITY(U,$J,358.3,7431,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,7432,0)
 ;;=275.9^^65^558^4
 ;;^UTILITY(U,$J,358.3,7432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7432,1,4,0)
 ;;=4^METABOLISM D/O,MINERAL
 ;;^UTILITY(U,$J,358.3,7432,1,5,0)
 ;;=5^275.9
 ;;^UTILITY(U,$J,358.3,7432,2)
 ;;=^267943
 ;;^UTILITY(U,$J,358.3,7433,0)
 ;;=588.0^^65^558^13
 ;;^UTILITY(U,$J,358.3,7433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7433,1,4,0)
 ;;=4^RENAL OSTEODYSTROPHY
 ;;^UTILITY(U,$J,358.3,7433,1,5,0)
 ;;=5^588.0
 ;;^UTILITY(U,$J,358.3,7433,2)
 ;;=^104747
 ;;^UTILITY(U,$J,358.3,7434,0)
 ;;=268.9^^65^558^14
 ;;^UTILITY(U,$J,358.3,7434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7434,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,7434,1,5,0)
 ;;=5^268.9
 ;;^UTILITY(U,$J,358.3,7434,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,7435,0)
 ;;=251.2^^65^559^16
 ;;^UTILITY(U,$J,358.3,7435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7435,1,4,0)
 ;;=4^HYPOGLYCEMIA NOS
 ;;^UTILITY(U,$J,358.3,7435,1,5,0)
 ;;=5^251.2
 ;;^UTILITY(U,$J,358.3,7435,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,7436,0)
 ;;=250.01^^65^559^7
 ;;^UTILITY(U,$J,358.3,7436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7436,1,4,0)
 ;;=4^DMI w/o COMPLICATIONS
 ;;^UTILITY(U,$J,358.3,7436,1,5,0)
 ;;=5^250.01
 ;;^UTILITY(U,$J,358.3,7436,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,7437,0)
 ;;=250.11^^65^559^3
 ;;^UTILITY(U,$J,358.3,7437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7437,1,4,0)
 ;;=4^DMI w/ KETOACIDOSIS
 ;;^UTILITY(U,$J,358.3,7437,1,5,0)
 ;;=5^250.11
 ;;^UTILITY(U,$J,358.3,7437,2)
 ;;=^331784
 ;;^UTILITY(U,$J,358.3,7438,0)
 ;;=250.21^^65^559^2
 ;;^UTILITY(U,$J,358.3,7438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7438,1,4,0)
 ;;=4^DMI w/ HYPEROSMOLARITY
 ;;^UTILITY(U,$J,358.3,7438,1,5,0)
 ;;=5^250.21
 ;;^UTILITY(U,$J,358.3,7438,2)
 ;;=^331788
 ;;^UTILITY(U,$J,358.3,7439,0)
 ;;=250.41^^65^559^5
 ;;^UTILITY(U,$J,358.3,7439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7439,1,4,0)
 ;;=4^DMI w/ RENAL COMPL
 ;;^UTILITY(U,$J,358.3,7439,1,5,0)
 ;;=5^250.41
 ;;^UTILITY(U,$J,358.3,7439,2)
 ;;=^331796
 ;;^UTILITY(U,$J,358.3,7440,0)
 ;;=250.51^^65^559^1
 ;;^UTILITY(U,$J,358.3,7440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7440,1,4,0)
 ;;=4^DMI w/ EYE COMPL
 ;;^UTILITY(U,$J,358.3,7440,1,5,0)
 ;;=5^250.51
 ;;^UTILITY(U,$J,358.3,7440,2)
 ;;=^331800
 ;;^UTILITY(U,$J,358.3,7441,0)
 ;;=250.61^^65^559^4
 ;;^UTILITY(U,$J,358.3,7441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7441,1,4,0)
 ;;=4^DMI w/ NEUROLOGICAL COMPL
 ;;^UTILITY(U,$J,358.3,7441,1,5,0)
 ;;=5^250.61
 ;;^UTILITY(U,$J,358.3,7441,2)
 ;;=^331804
 ;;^UTILITY(U,$J,358.3,7442,0)
 ;;=250.71^^65^559^6
 ;;^UTILITY(U,$J,358.3,7442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7442,1,4,0)
 ;;=4^DMI w/ VASCULAR COMPL
 ;;^UTILITY(U,$J,358.3,7442,1,5,0)
 ;;=5^250.71
 ;;^UTILITY(U,$J,358.3,7442,2)
 ;;=^331808
 ;;^UTILITY(U,$J,358.3,7443,0)
 ;;=250.00^^65^559^14
 ;;^UTILITY(U,$J,358.3,7443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7443,1,4,0)
 ;;=4^DMII w/o COMPLICATIONS
 ;;^UTILITY(U,$J,358.3,7443,1,5,0)
 ;;=5^250.00
 ;;^UTILITY(U,$J,358.3,7443,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,7444,0)
 ;;=250.10^^65^559^10
 ;;^UTILITY(U,$J,358.3,7444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7444,1,4,0)
 ;;=4^DMII w/ KETOACIDOSIS
 ;;^UTILITY(U,$J,358.3,7444,1,5,0)
 ;;=5^250.10
 ;;^UTILITY(U,$J,358.3,7444,2)
 ;;=^331783
 ;;^UTILITY(U,$J,358.3,7445,0)
 ;;=250.20^^65^559^9
 ;;^UTILITY(U,$J,358.3,7445,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7445,1,4,0)
 ;;=4^DMII w/ HYPEROSMOLARITY
 ;;^UTILITY(U,$J,358.3,7445,1,5,0)
 ;;=5^250.20
 ;;^UTILITY(U,$J,358.3,7445,2)
 ;;=^331787
 ;;^UTILITY(U,$J,358.3,7446,0)
 ;;=250.40^^65^559^12
 ;;^UTILITY(U,$J,358.3,7446,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7446,1,4,0)
 ;;=4^DMII w/ RENAL COMPL
 ;;^UTILITY(U,$J,358.3,7446,1,5,0)
 ;;=5^250.40
 ;;^UTILITY(U,$J,358.3,7446,2)
 ;;=^331795
 ;;^UTILITY(U,$J,358.3,7447,0)
 ;;=250.50^^65^559^8
 ;;^UTILITY(U,$J,358.3,7447,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7447,1,4,0)
 ;;=4^DMII w/ EYE COMPL
 ;;^UTILITY(U,$J,358.3,7447,1,5,0)
 ;;=5^250.50
 ;;^UTILITY(U,$J,358.3,7447,2)
 ;;=^331799
 ;;^UTILITY(U,$J,358.3,7448,0)
 ;;=250.60^^65^559^11
 ;;^UTILITY(U,$J,358.3,7448,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7448,1,4,0)
 ;;=4^DMII w/ NEUROLOGICAL COMPL
 ;;^UTILITY(U,$J,358.3,7448,1,5,0)
 ;;=5^250.60
 ;;^UTILITY(U,$J,358.3,7448,2)
 ;;=^331803
 ;;^UTILITY(U,$J,358.3,7449,0)
 ;;=250.70^^65^559^13
 ;;^UTILITY(U,$J,358.3,7449,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7449,1,4,0)
 ;;=4^DMII w/ VASCULAR COMPL
 ;;^UTILITY(U,$J,358.3,7449,1,5,0)
 ;;=5^250.70
 ;;^UTILITY(U,$J,358.3,7449,2)
 ;;=^331807
 ;;^UTILITY(U,$J,358.3,7450,0)
 ;;=272.0^^65^560^4
 ;;^UTILITY(U,$J,358.3,7450,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7450,1,4,0)
 ;;=4^PURE HYPERCHOLESTEROLEM
 ;;^UTILITY(U,$J,358.3,7450,1,5,0)
 ;;=5^272.0
 ;;^UTILITY(U,$J,358.3,7450,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,7451,0)
 ;;=272.1^^65^560^5
 ;;^UTILITY(U,$J,358.3,7451,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7451,1,4,0)
 ;;=4^PURE HYPERGLYCERIDEMIA
 ;;^UTILITY(U,$J,358.3,7451,1,5,0)
 ;;=5^272.1
 ;;^UTILITY(U,$J,358.3,7451,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,7452,0)
 ;;=272.2^^65^560^3
 ;;^UTILITY(U,$J,358.3,7452,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7452,1,4,0)
 ;;=4^MIXED HYPERLIPIDEMIA
 ;;^UTILITY(U,$J,358.3,7452,1,5,0)
 ;;=5^272.2
 ;;^UTILITY(U,$J,358.3,7452,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,7453,0)
 ;;=272.4^^65^560^1
 ;;^UTILITY(U,$J,358.3,7453,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7453,1,4,0)
 ;;=4^HYPERLIPIDEMIA NEC/NOS
 ;;^UTILITY(U,$J,358.3,7453,1,5,0)
 ;;=5^272.4
 ;;^UTILITY(U,$J,358.3,7453,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,7454,0)
 ;;=272.6^^65^560^2
 ;;^UTILITY(U,$J,358.3,7454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7454,1,4,0)
 ;;=4^LIPODYSTROPHY
 ;;^UTILITY(U,$J,358.3,7454,1,5,0)
 ;;=5^272.6
 ;;^UTILITY(U,$J,358.3,7454,2)
 ;;=^71106
 ;;^UTILITY(U,$J,358.3,7455,0)
 ;;=253.0^^65^561^1
 ;;^UTILITY(U,$J,358.3,7455,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7455,1,4,0)
 ;;=4^ACROMEGALY AND GIGANTISM
 ;;^UTILITY(U,$J,358.3,7455,1,5,0)
 ;;=5^253.0
 ;;^UTILITY(U,$J,358.3,7455,2)
 ;;=^2351
 ;;^UTILITY(U,$J,358.3,7456,0)
 ;;=255.0^^65^561^2
 ;;^UTILITY(U,$J,358.3,7456,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7456,1,4,0)
 ;;=4^CUSHING'S SYNDROME
 ;;^UTILITY(U,$J,358.3,7456,1,5,0)
 ;;=5^255.0
 ;;^UTILITY(U,$J,358.3,7456,2)
 ;;=^29802
 ;;^UTILITY(U,$J,358.3,7457,0)
 ;;=253.5^^65^561^3
 ;;^UTILITY(U,$J,358.3,7457,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7457,1,4,0)
 ;;=4^DIABETES INSIPIDUS
 ;;^UTILITY(U,$J,358.3,7457,1,5,0)
 ;;=5^253.5
 ;;^UTILITY(U,$J,358.3,7457,2)
 ;;=^33572
 ;;^UTILITY(U,$J,358.3,7458,0)
 ;;=253.8^^65^561^4
 ;;^UTILITY(U,$J,358.3,7458,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7458,1,4,0)
 ;;=4^EMPTY SELLA SYNDROME
 ;;^UTILITY(U,$J,358.3,7458,1,5,0)
 ;;=5^253.8
 ;;^UTILITY(U,$J,358.3,7458,2)
 ;;=^87533
 ;;^UTILITY(U,$J,358.3,7459,0)
 ;;=253.1^^65^561^5
 ;;^UTILITY(U,$J,358.3,7459,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7459,1,4,0)
 ;;=4^HYPERPROLACTINEMIA
 ;;^UTILITY(U,$J,358.3,7459,1,5,0)
 ;;=5^253.1
 ;;^UTILITY(U,$J,358.3,7459,2)
 ;;=^87260
 ;;^UTILITY(U,$J,358.3,7460,0)
 ;;=253.2^^65^561^6
 ;;^UTILITY(U,$J,358.3,7460,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7460,1,4,0)
 ;;=4^PANHYPOPITUITARISM
 ;;^UTILITY(U,$J,358.3,7460,1,5,0)
 ;;=5^253.2
 ;;^UTILITY(U,$J,358.3,7460,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,7461,0)
 ;;=227.3^^65^561^7
 ;;^UTILITY(U,$J,358.3,7461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7461,1,4,0)
 ;;=4^PITUITARY TUMOR,BENIGN
 ;;^UTILITY(U,$J,358.3,7461,1,5,0)
 ;;=5^227.3
